ДК 021:2015 – 33600000-6 Фармацевтична продукція (Доцетаксел 80 мг, Доцетаксел 20 мг)

Both sections are in contradiction. Please confirm, which is applicable: 6.2. Regarding an unregistered medicinal product Only medicines registered in Ukraine are allowed to participate in this procurement. 6.3. Regarding an unregistered medicinal product, included in the list of unregistered medicinal products (by international non-proprietary names), which can be imported into the territory of Ukraine for the purpose of supply based on the results of procurement carried out by a person authorized to carry out procurement in the field of health care, for the implementation of programs and implementation of centralized health care measures at the expense of the state budget, approved by Resolution No. 1182 of the Cabinet of Ministers of Ukraine dated November 15, 2021 6.3.1. A copy of the document confirming the registration of the medicinal product in the United States of America, the Swiss Confederation, Japan, Australia, Canada or registration by a competent authority of the European Union under a centralized procedure and application in the territory of one of these countries; 6.3.2. Copies: instructions for the use of the medicinal product (other information on the use of the medicinal product) in the original language (a language other than the official language) and a brief description of the medicinal product** in the original language (a language other than the official language), approved in accordance with the regulatory requirements of the country of the Applicant/Manufacturer or the United States of America, the Swiss Confederation, Japan, Australia, Canada, member states of the European Union, and ALSO a translation of the instructions for the use of the medicinal product (other information on the use of the medicinal product) and a brief description of the medicinal product in the national (Ukrainian) language. ** for drugs registered in Canada, instead of a short description of the drug, the participant can provide a full monograph on the drug / Product Monograph (part III of the monograph - information for the patient meets the requirement to provide information on the use of the drug); for drugs registered in the USA, instead of a short description of the drug, the participant can provide full prescribing information (part of full prescribing information - information for the patient meets the requirement to provide information on the use of the drug). (If a document written in a language other than Ukrainian is submitted as part of the tender offer, the participant must provide an authentic translation of such a document in Ukrainian. The text in Ukrainian is decisive. The participant is responsible for the authenticity of the translation).